+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

5-HT1B Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1B Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Receptor Tyrosine Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

SRC Family Kinases (SFK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Androgen Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Kappa Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Kappa Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Delta Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Delta Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Progesterone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Progesterone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Factor IX A Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Factor IX A Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PDE 1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PDE 1 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PDE Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PDE Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
CCR5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha Glucosidase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha Glucosidase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta-2 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-2 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator